Skip to main content

How, When, and Where Do Human β-Cells Regenerate?

Citation
Basile, G., et al. “How, When, And Where Do Human Β-Cells Regenerate?”. Current Diabetes Reports, p. 48.
Center Joslin Diabetes Center
Author Giorgio Basile, Rohit N Kulkarni, Noel G Morgan
Keywords diabetes, islets of Langerhans, Ki67, proliferation, Transdifferentiation, β-cell mass
Abstract

PURPOSE OF REVIEW: Pancreatic β-cells play a critical role in whole-body glucose homeostasis by regulating the release of insulin in response to minute by minute alterations in metabolic demand. As such, β-cells are staunchly resilient but there are circumstances where they can become functionally compromised or physically lost due to pathophysiological changes which culminate in overt hyperglycemia and diabetes.

RECENT FINDINGS: In humans, β-cell mass appears to be largely defined in the postnatal period and this early replicative and generative phase is followed by a refractory state which persists throughout life. Despite this, efforts to identify physiological and pharmacological factors which might re-initiate β-cell replication (or cause the replenishment of β-cells by neogenesis or transdifferentiation) are beginning to bear fruit. Controlled manipulation of β-cell mass in humans still represents a holy grail for therapeutic intervention in diabetes, but progress is being made which may lead to ultimate success.

Year of Publication
2019
Journal
Current diabetes reports
Volume
19
Issue
8
Number of Pages
48
Date Published
12/2019
ISSN Number
1539-0829
DOI
10.1007/s11892-019-1176-8
Alternate Journal
Curr. Diab. Rep.
PMID
31250214
PMCID
PMC6986204
Download citation